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HE IN IT IAL RESULTS OF HUMAN CL IN ICAL STUDIES DEMONSTRATED
HE SAFETY AND POTENTIAL BENEF IT OF autologous bone marrow cells in
mproving left ventricular function after acutemyocardial infarction (AMI). However, a fundamental problem
n developing stem cell (SC)–based therapies has been the inability to monitor the engraftment and spatial
igration of SCs in vivo following intracoronary or intramyocardial injection (1). Several integrative
pproaches have been suggested, such as cardiac magnetic resonance in combination with single-photon
mission computed tomography (direct labeling of the cells with iron and nuclear particles), or positron
mission tomography (PET) in combination with computed tomography (CT) and bioluminescence (indirect
abeling of the cells, such as PET, ﬂuorescence, or bioluminescence reporter gene method) (2). We have
reviously demonstrated the serial noninvasive imaging of the intramyocardially transplanted SCs, modiﬁed
or stable expression of PET–reporter gene, in large animal models such as pigs which may have direct
elevance for human studies (3). Here we report the ﬁrst in vitro bioluminescence imaging of the SCs
odiﬁed for transient expression of Luciferase (Luc) gene for characterizing their biodistribution after
ercutaneous intracoronary and intramyocardial delivery in pig hearts.
losed-chest reperfused AMI was created in domestic pigs with 90-min percutaneous occlusion of the
eft anterior descending coronary artery followed by reperfusion. Three weeks after AMI, 3-dimensional
3D) NH3-PET-CT was performed to image the myocardial perfusion defect at the anterior wall (Fig. 1A)
nd the left ventricular function disturbance with cardiac magnetic resonance (Fig. 1B). Porcine
esenchymal stem cells (MSC) were transfected with PET-reporter (MSC-PET-reporter) and injected
ntramyocardially using 3D NOGA mapping (Biologics Delivery Systems Group of Cordis Corporation,
ohnson & Johnson, Diamond Bar, California) guidance in 8 locations (Fig. 1C). The 3D NOGA-guided
ntramyocardial delivery of SC helps retain the SC in the myocardium with minimal washout and
educed distribution to other organs (2). A corresponding PET-CT image showed conﬂuent PET tracer
ctivities (Fig 1D). In order to enable separation of the injection sites, MSC-PET-reporters were injected
rom the *Department of Cardiology, Medical University of Vienna, Vienna, Austria; †Ludwig Boltzmann Institute for
linical and Experimental Traumatology/AUVA Research Center Austrian Cluster for Tissue Regeneration, Vienna, Austria;
PET Centrum–Institute of Nuclear Medicine of the University of Debrecen, Debrecen, Hungary; §Institute of Diagnostic
maging and Radiation Oncology, University of Kaposvar, Kaposvar, Hungary; and the Centro de Investigacion Cardiovascular
CSIC-ICCC), Barcelona, Spain. This study was supported by the Ludwig Boltzmann Institute Cluster for Cardiovascular
esearch and the Biologics Delivery Systems Group, Cordis Corporation. The PET-reporter gene was the kind donation of
anjiv Sam Gambhir, MD, PHD, Departments of Radiology and Bioengineering, Stanford University, Stanford, California, in
ooperation with Centro de Investigacion Cardiovascular (CSIC-ICCC), Barcelona, Spain.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 7 , 2 0 1 0
J U L Y 2 0 1 0 : 7 7 2 – 5
Gyöngyösi et al.
Imaging of Cardially Delivered Stem Cells
773Figure 1. Imaging Modalities in a Porcine Model of Anterior Wall MI and Stem Cell Delivery
(A) 3-Dimensional (3D) NH3-positron emission tomography (PET) combined with computed tomography (CT) image of the anterior wall myocardial infarction
(MI) (Online Video 1) in a pig (supine position). Tracer uptake (red) defect in the apex (yellow arrow). (B) End-diastolic cardiac magnetic resonance image with
aneurysm of the anterior wall and apex. Left lateral view (left anterior oblique 90°) (Online Video 2). (C) 3D NOGA unipolar voltage mapping with NOGA-guided
intramyocardial injection points of the mesenchymal stem cells (MSC), modiﬁed for stable expression of PET–reporter gene (MSC-PET-reporter) at the border
zone of the anterior wall MI (black points, yellow arrows) (anteroposterior projection), 3 weeks after MI. Red color indicates the loss of electrical activity (infarcted
area), blue the normal voltage signal (normal myocardium), and green and yellow the decreased viability (infarct border zone) (Online Video 3). Note that the
pig heart is oriented vertically with the apex pointing slightly to the right. (D) [18F]-labeled 9-[4-ﬂuoro-3-(hydroxymethyl)butyl]guaninderivatives ([18F]-FHBG)–
PET-CT of a pig (supine position, same position as in panel A) representing the intramyocardial injection sites (corresponding PET-CT of the heart displayed in
panel C) with the MSC-PET-reporter (white arrow) with high tracer activities, 10 hours after MSC-PET-reporter delivery. (E) 3D NOGA unipolar voltage mapping
with 2 locations of NOGA-guided intramyocardial injections (black points, yellow arrows) of the MSC-PET-reporter at the border zone of the anterior wall MI
(anteroposterior projection). Same color coding as in panel C. Injections of 2 distant points were necessary to enable the separation of the cell delivery locations
in PET-CT images. (F) 18F-FHBG-PET-CT image of the same pig (supine position, same position as in panel A) 10 hours after 2 NOGA-guided intramyocardial
injections of the MSC-PET-reporter (white arrows), corresponding PET-CT image of the heart displayed in panel E. (G) In vivo tracking of the intramyocardially
delivered MSC-PET-reporter with serial noninvasive PET-CT images of a pig heart at an additional 16 and 20 hours (H). 18F-FHBG-PET-CT images of the pig in
a supine position (same position as in panel A). Gradual decrease of the tracer activity in the heart (white arrows) and increase in the surrounding tissues.
(H) Further decrease of number of MSC-PET-reporter at 20 hours (white arrows) after delivery, suggesting the migration or death of the cells. L  left side;
R  right side; S  sternum; V  vertebra.
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774Figure 2. In Vitro Tracking of the Percutaneously Intramyocardially Delivered MSCs, Modiﬁed for Transient Expression of MSC-Luc in a Pig Heart and
Remote Organs Using Bioluminescence Imaging at 3 Hours After Delivery
(A) Cross sections of the pig myocardium (1 cm thick slices from apex to mitral ring/from a to g). Hot spots in the border zone of infarction, corresponding with
the location of the NOGA-guided endocardial-intramyocardial injections of MSC-Luc (yellow arrows). One hot spot below the pericardial surface of the myocar-
dium (white arrow), suggesting either deep injection or cell migration from the endoluminal surface of the ventricle. (B) Low bioluminescent signal in the peri-
cardium (arrow), without visible bioluminescent signal of the endocardial surface of another pig heart. (C) No MSC-Luc in the lung. (D) No bioluminescent signal
in the liver parenchyma, but one high hot spot in the portal lymph node (arrow). (E) Weak MSC-Luc-signal in the spleen hilus (arrow). (F) High intensity of
bioluminescent signal in the bone marrow (green arrows) and one hot spot in the skin (yellow arrow). (G) Bioluminescent activities in the inguinal and portal
lymph nodes (yellow arrows). (H) No MSC-Luc detected in the kidney, but bioluminescent activity in the abdominal lymph nodes (arrow). Luc  luciferase gene;
other abbreviation as in Figure 1.Figure 3. In Vitro Tracking of the Intracoronary Delivered MSCs, Modiﬁed for Transient Expression of MSC-Luc in a Pig Heart and Remote Organs Using
Bioluminescence Imaging at 3 Hours After Delivery
The bioluminescent signal intensity is much higher in the remote organs, as compared to the intramyocardial delivery mode. (A) Cross sections of the pig myo-
cardium (1 cm thick slices from apex to mitral ring/from a to f). Weak bioluminescent signal in the border zone of infarction in one section (arrow). (B) High
bioluminescent activity in the pericardium (arrow), with no cells visible in the myocardium of another pig heart. (C) Hot spots of the left lung. (D) No biolumi-
nescent signal in the liver parenchyma, but high activity in the blood pool of the liver (green arrow) and in the portal lymph node (yellow arrow). (E) Presence
of MSC-Luc in the spleen hilus (arrow), but not in the spleen. (F) Very high intensity of bioluminescent signal in the spongiotic tissue of the sternum (e.g. bone
marrow) (arrows), as early as 3 hours after MSC-Luc intracoronary delivery. (G) Hot spot in the skin (arrow). (H) No MSC-Luc detected in the kidney, but some
bioluminescent activity in abdominal lymph nodes (arrow). Abbreviations as in Figures 1 and 2.
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775n 2 distinct locations (Fig. 1E) and tracked with serial PET images (Figs. 1F, 1G, and 1H). To overcome
he low spatial resolution of the PET images and fast decay of the PET tracer, and to verify the biodistribution
f the cells in remote organs, pig MSCs were transfected with Luc (MSC-Luc), and delivered intramyocardially
r intracoronary. In vitro bioluminescence imaging of MSC-Luc (Figs. 2 and 3) indicated a higher degree of
ell distribution in remote organs after intracoronary cell delivery and the retention of the cells mostly in the
ymph nodes, bone marrow, and blood pool. The underlying mechanism of migration to remote organs,
hether active or passive, remains unclear.
he in vivo and in vitro tracking of the cardially delivered SCs provides the ability to explore the fate
nd distribution of SCs. Future studies are required for characterizing molecular technologies that
nhance SC engraftment in the heart while avoiding the unnecessary migration to remote organs.
urthermore, the development of safe and efﬁcient self-activating and -inactivating vectors is currently
nder way for the pre-clinical and clinical use of reporter gene imaging.
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